Effect Of Vitamin D Administration On Interleukin 6 (IL-6) Levels In Peritoneal Fluid In Endometrioma Patients
DOI:
https://doi.org/10.36408/mhjcm.v11i3.1031Keywords:
Endometrioma, Interleukin 6, Peritoneal Fluid, vitamin DAbstract
BACKGROUND: An endometrioma is a cyst that occurs when endometrial tissue grows on the epithelium of the ovary. Vitamin D is a steroid hormone that can be extracted from commonly available foods and can be synthesized by humans when exposed to sunlight. Vitamin D deficiency has been reported to be associated with various pathologies, including endometrioma. Vitamin D has been reported to have anti-angiogenic effects that may inhibit the growth of endometriotic implants.
AIM: Proving the effect of vitamin D administration on interleukin 6 (IL-6) levels in peritoneal fluid in patients with endometrioma.
METHOD: Experimental research with two group, post-test only design with single blind that carried out at Central General Hospital (RSUP) Dr. Kariadi Semarang. The research subject was 50 patients with endometrioma on ovary. The definite diagnosis of endometrioma is made based on histopathological examination of tissue samples after the patient undergoes surgery. Patients will be divided into 2 groups, namely the vitamin D3 supplementation group and placebo. The intervention was carried out by providing vitamin D3 50,000 IU/week for a month. Evaluation of serum vitamin D levels were obtained using venous blood samples immediately when the patient was undergoing surgery. Interlukin-6 levels were obtained using peritoneal fluid samples obtained when the patient underwent surgery. Statistical analysis was carried out using the Independent T Test, Mann-Whitney U, Dependent T Test and Wilcoxon. Results are significant if p <0.05. Statistical analysis was carried out using SPSS edition 26.
RESULT: Peritoneal fluid interleukin-6 (IL-6) levels between the vitamin D supplementation group and the placebo group did not show a significant difference (p=0.554).
CONCLUSION: Vitamin D supplementation in endometrioma patients is not associated with peritoneal fluid interleukin-6 (IL-6) levels.
Downloads
References
1. Li S, Fu X, Wu T, Yang L, Hu C, Wu Role of interleukin-6 and its receptor in Endometriosis Med Sci Monit. 2017;23:3801.
2. Wardhana AP, Irwanto Y. Effect of Genistein on Proliferating Cell Nuclear Antigen (PCNA) Expression and Vascular Density in The Peritoneum of Endometriosis Mice Model. Asian Journal of Health Research. 2023 Dec 14;2(3):5–11. https://doi.org/10.55561/ajhr.v2i3.104
3. Moradi Y, Shams-Beyranvand M, Khateri S, Gharahjeh S, Tehrani S, Varse F, et al. A systematic review on the prevalence of Endometriosis Indian Journal of Medical Research. 2021;154(3):446. https://doi.org/10.4103/ijmr.IJMR_817_18
4. Simopoulou M, Rapani A, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, et al. Getting to know Endometriosis -related infertility better: a review on how Endometriosis affects oocyte quality and embryo Biomedicines. 2021;9(3):273.
5. Lamceva J, Uljanovs R, Strumfa I. The Main Theories on the Pathogenesis of Int J Mol Sci. 2023 Feb 21;24(5):4254. https://doi.org/10.3390/ijms24054254
6. Incognito GG, Di Guardo F, Gulino FA, Genovese F, Benvenuto D, Lello C, et al. Interleukin-6 as A Useful Predictor of Endometriosis – Associated Infertility: A Systematic Review. I n t J F e r t i l S t e r i l . 2 0 2 3 A u g 7 ; 1 7 ( 4 ) : 2 2 6 – 3 0 . https://doi.org/10.22074/ijfs.2023.557683.1329
7. Baboo KD, Chen ZY, Zhang XM. Role of oxidative stress and antioxidant therapies in Reproductive and Developmental Medicine. 2019;3(03):170–6.
8. Oală IE, Mitranovici MI, Chiorean DM, Irimia T, Cri an AI, Melinte IM, et al. Endometriosis and the Role of Pro- Inflammatory and Anti-Inflammatory Cytokines in Pathophysiology: A Narrative Review of the Literature. D i a g n o s t i c s . 2 0 2 4 J a n 3 1 ; 1 4 ( 3 ) : 3 1 2 . https://doi.org/10.3390/diagnostics14030312
9. Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory mediators and pain in Endometriosis: a systematic review. Biomedicines. 2021;9(1):54.
10. Xie B, Liao M, Huang Y, Hang F, Ma N, Hu Q, et al. Association between vitamin D and Endometriosis among American women: National Health and Nutrition Examination Survey. P L o S O n e . 2 0 2 4 J a n 1 2 ; 1 9 ( 1 ) : e 0 2 9 6 1 9 0 . https://doi.org/10.1371/journal.pone.0296190
11. Fraser Physiological significance of vitamin D produced in skin compared with oral vitamin D. J Nutr Sci. 2022 Feb 21;11:e13. https://doi.org/10.1017/jns.2022.11
12. Cermisoni GC, Alteri A, Corti L, Rabellotti E, Papaleo E, Viganò P, et al. Vitamin D and endometrium: A systematic review of a neglected area of research. Int J Mol Sci. 2018;19(8):1–13. https://doi.org/10.3390/ijms19082320
13. Krajewska M, Witkowska- Sędek E, Rumińska M, Stelmaszczyk-Emmel A, Sobol M, Majcher A, et al. Vitamin D Effects on Selected Anti-Inflammatory and Pro-Inflammatory Markers of Obesity-Related Chronic Front E n d o c r i n o l ( L a u s a n n e ) . 2 0 2 2 J u n 1 3 ; 1 3 . https://doi.org/10.3389/fendo.2022.920340
14. Athanassiou L, Mavragani CP, Koutsilieris M. The Immunomodulatory Properties of Vitamin D. Mediterr J 2022;33(1):7. https://doi.org/10.31138/mjr.33.1.7
15. Ashtari F, Madanian R, Zarkesh S, Ghalamkari Serum levels of interleukin-6 and Vitamin D at the onset of multiple sclerosis and neuromyelitis optica: A pilot study. Journal of Research in M e d i c a l S c i e n c e s . 2 0 2 2 ; 2 7 ( 1 ) : 6 7 . https://doi.org/10.4103/jrms.jrms_796_21
16. Kouchek M, Shojaei S, Amniati S, Ghaffari M, Salarian S, Miri MM, et al. Effect of High-dose Vitamin D on IL-1β Blood Level in Patients with Moderate Stroke: A Randomized Clinical Trial. A n e s t h P a i n M e d . 2 0 2 3 A u g 1 9 ; 1 3 ( 4 ) . https://doi.org/10.5812/aapm-138810
17. Konrad L, Dietze R, Kudipudi PK, Horné F, Meinhold-Heerlein I Endometriosis MRKH cases as a proof for the coelomic metaplasia hypothesis? Reproduction. 2019 Aug;158(2):R41–7. https://doi.org/10.1530/REP-19-0106
18. Divakar U, Sathish T, Soljak M, Bajpai R, Dunleavy G, Visvalingam N, et al. Prevalence of Vitamin D Deficiency and Its Associated Work-Related Factors among Indoor Workers in a Multi-Ethnic Southeast Asian Int J Environ Res Public H e a l t h . 2 0 1 9 D e c 2 5 ; 1 7 ( 1 ) : 1 6 4 . https://doi.org/10.3390/ijerph17010164
19. Khodadadiyan A, Rahmanian M, Shekouh D, Golmohammadi M, Ghaedi A, Bazrgar A, et al. Evaluating the effect of vitamin D supplementation on serum levels of 25-hydroxy vitamin D, 1,25-dihydroxy vitamin D, parathyroid hormone and reninangiotensinaldosterone system: a systematic review and meta-analysis of clinical BMC Nutr. 2023 Nov 15;9(1):132. https://doi.org/10.1186/s40795-023-00786-x
20. Best CM, Zelnick LR, Thummel KE, Hsu S, Limonte C, Thadhani R, et al. Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL- J Clin Endocrinol Metab. 2022 Jan 18;107(2):525–37. https://doi.org/10.1210/clinem/dgab693
21. Roizen JD, Levine MA. Vitamin D Therapy and the Era of Precision Medicine. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e891–3. https://doi.org/10.1210/clinem/dgz120
22. Enlund-Cerullo M, Koljonen L, Holmlund-Suila E, Hauta-alus H, Rosendahl J, Valkama S, et al. Genetic Variation of the Vitamin D Binding Protein Affects Vitamin D Status and Response to Supplementation in Infants. J Clin Endocrinol M e t a b . 2 0 1 9 N o v 1 ; 1 0 4 ( 1 1 ) : 5 4 8 3 – 9 8 . https://doi.org/10.1210/jc.2019-00630
23. El Hajj C, Walrand S, Helou M, Yammine Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. 2020 Jul 9;12(7):2033. https://doi.org/10.3390/nu12072033
24. Grebenciucova E, VanHaerents Interleukin 6: at the interface of human health and disease. Front Immunol. 2023 Sep 28;14. https://doi.org/10.3389/fimmu.2023.1255533
25. Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL- 6/JAK/STAT3 signalling axis in Nat Rev Clin Oncol. 2 0 1 8 A p r 6 ; 1 5 ( 4 ) : 2 3 4 – 4 8 . https://doi.org/10.1038/nrclinonc.2018.8
26. Huang B, Lang X, Li The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. 2022 Dec 16;12. https://doi.org/10.3389/fonc.2022.1023177
27. Cheng M, Liu P, Xu LX. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory J I n o r g B i o c h e m . 2 0 2 0 S e p ; 2 1 0 : 1 1 1 1 5 9 . https://doi.org/10.1016/j.jinorgbio.2020.111159
28. Ao T, Kikuta J, Ishii M. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules. 2021 Nov 3;11(11):1624. https://doi.org/10.3390/biom11111624
29. Sîrbe C, Rednic S, Grama A, Pop An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases. I n t J M o l S c i . 2 0 2 2 A u g 2 9 ; 2 3 ( 1 7 ) : 9 7 8 4 . https://doi.org/10.3390/ijms23179784
30. Neve A, Corrado A, Cantatore FP. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clin Exp M e d . 2 0 1 4 A u g 4 ; 1 4 ( 3 ) : 2 7 5 – 8 3 . https://doi.org/10.1007/s10238-013-0249-2
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Singgeh Setyasworo, Arufiadi Anityo Mochtar, Erwinanto, Herman Kristanto, Hary Tjahjanto, Yuli Trisetiyono (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
